Chu, Ran

No ORCID on file · 4 papers in corpus
article 2024
Additional file 1 of Injectable hydrogel nanoarchitectonics with near-infrared controlled drug delivery for in situ photothermal/endocrine synergistic endometriosis therapy
·doi:10.6084/m9.figshare.26624470

Additional file 1: Figure S1. SEM images of PDA. Figure S2. The extinction coefficient of PDA at 808 nm. Figure S3. The temperature record of a single photoperiod of PDA solution. Figure S4. The standard curve of LTZ. Figure S5. UV-vis spec…

article 2024
Additional file 1 of Injectable hydrogel nanoarchitectonics with near-infrared controlled drug delivery for in situ photothermal/endocrine synergistic endometriosis therapy
·doi:10.6084/m9.figshare.26624470.v1

Additional file 1: Figure S1. SEM images of PDA. Figure S2. The extinction coefficient of PDA at 808 nm. Figure S3. The temperature record of a single photoperiod of PDA solution. Figure S4. The standard curve of LTZ. Figure S5. UV-vis spec…

other 2024
Injectable hydrogel nanoarchitectonics with near-infrared controlled drug delivery for in situ photothermal/endocrine synergistic endometriosis therapy
·doi:10.6084/m9.figshare.c.6870665

Abstract Background Endometriosis is a common gynecological disease in women of childbearing age. Commonly used treatment methods, such as endocrine and surgical therapies, display poor therapeutic effects with a high relapse probability. T…

other 2024
Injectable hydrogel nanoarchitectonics with near-infrared controlled drug delivery for in situ photothermal/endocrine synergistic endometriosis therapy
·doi:10.6084/m9.figshare.c.6870665.v1

Abstract Background Endometriosis is a common gynecological disease in women of childbearing age. Commonly used treatment methods, such as endocrine and surgical therapies, display poor therapeutic effects with a high relapse probability. T…